Haejin In, MD, MPH, MBA, FACS, FSSO, discusses the importance of identifying individuals at high risk for developing gastric cancer.
Haejin In, MD, MPH, MBA, FACS
Advertisement
Articles by Haejin In, MD, MPH, MBA, FACS
Haejin In, MD, MPH, MBA, FACS, FSSO, discusses the increased incidence of gastric cancer in minority patient populations, highlighting the disparities that lead to these patient outcomes in the United States.
It is crucial to develop screening programs for stomach cancer in the United States in order to make diagnoses at earlier stages of disease, provide better care, and improve outcomes.
Advertisement
Latest Updated Articles
Dr In on the Importance of Early Cancer Prevention Strategies in Gastric CancerPublished: January 9th 2024 | Updated:
Dr In on the Increased Incidence of Gastric Cancer in Minority Patient PopulationsPublished: November 21st 2023 | Updated:
Can We Preempt Emergency Department Diagnoses of Stomach Cancer?Published: August 1st 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma
5